Literature DB >> 27512429

The effect of pregnancy on venous valve repair to the sapheno-femoral junction for varicose veins.

Martijn L Dijkstra1, Nyan Y Khin2, John C Coroneos3, Stuart Hazelton3, Rodney J Lane4.   

Abstract

OBJECTIVES: Pregnancy represents a special situation where both the mechanical and hormonal instigating factors of varicose veins are reversible with the venous valve cusps preserved. Exostent venous valve repairs are a physiological alternative which minimises stimulus to collateral growth (recurrence). The study purpose was to assess the effect of pregnancy on the durability of valve repairs.
METHODS: In a prospective study of 36 limbs, 20 young females (30 ± 4.7 years) had an exostent implanted to the terminal valve of the saphenofemoral junction for varicose veins. At routine long-term follow up (9.7 ± 3.8 years), 38 pregnancies were completed (mean: 1.8, range: 1-4). The controls were a non-pregnant group of limbs (n = 386).
RESULTS: At 9.7 years, the internal diameter of the greater saphenous vein (GSV) changed from 7.8 ± 2.8 mm preoperatively to 4.5 ± 1.4 mm post-operatively. Recurrence was associated with reflux, preoperative deep system and ovarian vein involvement. Pregnancy induced 33.3% recurrences compared with non-pregnant controls (4.7%) similarly treated or 22.8% compared with non-pregnant ablative controls. At 9.7 years, symptomatic improvement continued with significantly better CEAP status (described later) (31CSEAP preoperative to 6CSEAP) with no further truncal ablation (strip, laser) required.
CONCLUSIONS: Venous valve repairs can withstand the special stresses of pregnancy. There is no need to ablate the GSV. This approach is contrary to the traditional dictum; the treatment of varicose veins should be delayed until the family is completed.

Entities:  

Keywords:  cardiovascular; multiple pregnancy

Year:  2014        PMID: 27512429      PMCID: PMC4934948          DOI: 10.1177/1753495X14522617

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  16 in total

1.  Estrogen and progesterone receptors in normal and varicose saphenous veins.

Authors:  A Mashiah; V Berman; H H Thole; S S Rose; S Pasik; H Schwarz; H Ben-Hur
Journal:  Cardiovasc Surg       Date:  1999-04

2.  The effect of pregnancy on the lower-limb venous system of women with varicose veins.

Authors:  C Sparey; N Haddad; G Sissons; S Rosser; L de Cossart
Journal:  Eur J Vasc Endovasc Surg       Date:  1999-10       Impact factor: 7.069

Review 3.  Interventions for varicose veins and leg oedema in pregnancy.

Authors:  A A Bamigboye; R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

4.  Varicose veins of pregnancy.

Authors:  D J MULLANE
Journal:  Am J Obstet Gynecol       Date:  1952-03       Impact factor: 8.661

5.  Prevalence of varicose veins in an Italian elderly population.

Authors:  S Canonico; C Gallo; G Paolisso; F Pacifico; G Signoriello; G Sciaudone; N Ferrara; V Piegari; M Varricchio; F Rengo
Journal:  Angiology       Date:  1998-02       Impact factor: 3.619

6.  Repair of incompetent venous valves: a new technique.

Authors:  G Jessup; R J Lane
Journal:  J Vasc Surg       Date:  1988-11       Impact factor: 4.268

7.  Long-term comparison of external valvular stenting and stripping of varicose veins.

Authors:  Rodney J Lane; Joseph A Graiche; John C Coroneos; Michael L Cuzzilla
Journal:  ANZ J Surg       Date:  2003-08       Impact factor: 1.872

8.  The treatment of varicose veins with external stenting to the saphenofemoral junction.

Authors:  Rodney James Lane; Michael Luciano Cuzzilla; John Christopher Coroneos
Journal:  Vasc Endovascular Surg       Date:  2002 May-Jun       Impact factor: 1.089

Review 9.  Epidemiology of varicose veins.

Authors:  M J Callam
Journal:  Br J Surg       Date:  1994-02       Impact factor: 6.939

10.  Recurrence rates following external valvular stenting of the saphenofemoral junction: a comparison with simultaneous contralateral stripping of the great saphenous vein.

Authors:  R J Lane; M L Cuzzilla; J C Coroneos; M N Phillips; J T Platt
Journal:  Eur J Vasc Endovasc Surg       Date:  2007-09-18       Impact factor: 7.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.